IDBS has announced a collaboration with PerkinElmer, focusing on improving data analysis and interpretation of high content screening (HCS), an enabling technology in the search for key cellular markers associated with human health and disease.
The collaboration features the integration of PerkinElmer's Columbus image data management system for HCS with IDBS's ActivityBase XE screening data management software. The collaboration will provide researchers with a unified interface to access both Columbus's image data storage capabilities and ActivityBase XE's screening data analysis and interpretation features, to enable compelling exploratory outcomes in HCS and cellular analysis.
'The future of HCS lies in an increased synergy between technologies that integrate vast image content with large compound sets, to generate actionable research data,' said Richard M Eglen, president of bio-discovery at PerkinElmer. 'We feel this collaboration with IDBS is a timely and highly promising advance in giving researchers access to greater insights into the cell-based mechanisms of disease, as well as development of novel therapies based on greater understanding of the origins of diseases.'
Neil Kipling, CEO of IDBS, said: 'ActivityBase XE maintains IDBS's leading position in data management for the global drug discovery industry, offering innovation and scalable functionality to screening groups worldwide. This new relationship with PerkinElmer provides scientists with the high performance data management tools necessary to maximise the promise that this technical innovation presents.'
